Expression of NF-κB parallels COX-2 expression in oral precancer and cancer: Association with smokeless tobacco

International Journal of Cancer

Volumn 120, Issue 12, 2007, Pages 2545-2556

  Sawhney, Meenakshi ^a   Rohatgi, Nidhi ^a   Kaur, Jatinder ^a   Shishodia, Shishir ^b   Sethi, Gautam ^b   Gupta, Siddhartha D ^a   Deo, Suryanaryana V S ^c   Shukla, Nootan K ^c   Aggarwal, Bharat B ^b   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF TEXAS   (United States)

^c INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

Clinical correlation; COX 2; NF kappaB; Oral cancer; Oral precancerous lesions; Smokeless tobacco

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; MEMBRANE PROTEIN; NITROSAMINE; OLIGONUCLEOTIDE; PLANT EXTRACT; PTGS2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CARCINOGENESIS; CLINICAL EXAMINATION; CONFOCAL LASER MICROSCOPY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DYSPLASIA; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; MOUTH TUMOR; PRIORITY JOURNAL; SMOKELESS TOBACCO; SQUAMOUS CELL CARCINOMA; UPREGULATION; WESTERN BLOTTING; AGED; BIOSYNTHESIS; CHEMISTRY; CHI SQUARE DISTRIBUTION; CONFOCAL MICROSCOPY; CYTOPLASM; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER; PROTEIN BINDING; TIME; TUMOR CELL LINE;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHI-SQUARE DISTRIBUTION; CYCLOOXYGENASE 2; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; MOUTH NEOPLASMS; NF-KAPPA B; NITROSAMINES; OLIGONUCLEOTIDES; PLANT EXTRACTS; PRECANCEROUS CONDITIONS; PROTEIN BINDING; TIME FACTORS; TOBACCO, SMOKELESS;

EID: 34247499895     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22657     Document Type: Article

References (44)

1. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide, Version 1.0. Lyon: IARC Press, 2005. IARC Cancer Base No. 5.
2. Gupta PC, Ray CS. Smokeless tobacco and health in India and South Asia. Respirology 2003;8:419-31.
3. Cogliano V, Straif K, Baan R, Grosse Y, Secretan B, Ghissassi F. Smokeless tobacco and related nitrosamines. Lancet Oncol 2004;5:708.
4. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005;5:127-35.
5. Yildiz D, Liu YS, Ercal N, Armstrong DW. Comparison of pure nicotine- and smokeless tobacco extract-induced toxicities and oxidative stress. Arch Environ Contain Toxicol 1999;7:434-9.
6. Aggarwal BB. NF-κB: the enemy within. Cancer Cell 2004;6:203-8.
7. Nakanishi C, Toi M. Nuclear factor-κB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005;5:297-309.
8. Shishodia S, Aggarwal BB. Nuclear factor-κB: a friend or a foe in cancer? Biochem Pharmacol 2004;68:1071-80.
9. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, Angelo M, De Marzo . Cyclooxygenases in cancer: progress and perspective. Cancer Lett 2004;215:1-20.
10. Hull MA. Cyclooxygenase-2: how good is it as a target for cancer chemoprevention? Eur J Cancer 2005;41:1854-63.
11. Mohan S, Epstein JB. Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer. Oral Oncol 2003;39:537-46.
12. Banerjee AG, Gopalakrishnan VK, Bhattacharya I, Vishwanatha JK. Deregulated cyclooxygenase-2 expression in oral premalignant tissues. Mol Cancer Ther 2002;1:1265-71.
13. Shibata M, Kodani I, Osaki M, Araki K, Adachi H, Ryoke K, Ito H. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 2005;41:304-12.
14. Jackel EC, Raja S, Tan J, Das SK, Dey SK, Griod DA. Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, peroxisome proliferator-activator receptor (Δ) with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2001;127:1253-59.
15. Nakayama H, Ikebe T, Beppu M, Shirasuna K. High expression levels of nuclear factor κB, IκB kinase α and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer 2001;92:3037-44.
16. Kaur J, Ralhan R. Establishment and characterization of a cell line from smokeless tobacco associated oral squamous cell carcinoma. Oral Oncol 2003;39:806-20.
17. Rohatgi N, Kaur J, Srivastava A, Ralhan R. Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia. Oral Oncol 2005;41:806-20.
18. Union Internationale Centre Le Cancer. TNM classification of malignant tumors,3rd edn. Geneva: UICC, 1988.
19. Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 2005;11:2272-84.
20. Jaju RJ, Patel RK, Bakshi SR, Trivedi AH, Dave BJ, Adhvaryu SG. Chromosome damaging effects of pan masala. Cancer Lett. 1992;65: 221-6.
21. Witcher M, Ross DT, Rousseau C, Deluca L, Miller WH, Jr. Synergy between all-trans retinole acid and tumor necrosis factor pathways in acute leukemia cells. Blood 2003;102:237-45.
22. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;7:4350-4.
23. Shishodia S, Majumdar S, Banerjee S, Aggarwal BB. Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, cyclin D1. Cancer Res 2003;63:4375-83.
24. Petro TM. Modulation of IL-12 p35 and p40 promoter activity by smokeless tobacco extract is associated with an effect upon activation of NF-κB but not IRF transcription factors. Int Immunopharmacol 2003;3:735-45.
25. Vishwanatha JK, Swinney R, Banerje AG. Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer. Mol Cell Biochem 2003;248:67-75.
26. Johnson GK, Poore TK, Payne JB, Organ CC. Effect of smokeless tobacco extract on human gingival keratinocyte levels of prostaglandin E2 and interleukin-1. J Periodontol 1996;67:116-24.
27. Bindhu OS, Ramadas K, Sebastian P, Pillai MR. High expression levels of nuclear factor κB and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 2006;28:916-25.
28. Sudbo J, Ristimaki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M. Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. Oral Oncol 2003;39:497-505.
29. Chan G, Boyle JO, Yang EK, Zhang F, Sacks PG, Shah JP, Edelstein D, Soslow RA, Koki A, Woerner BM. Masferrer JL, Dannenberg AJ. Cyclooxygenase-2 expression up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 1999;59:991-994.
30. Itoh S, Matsui K, Furut I, Takano Y. Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor. Oral Oncol 2003;39:829-35.
31. Santhi WS, Sebastian P, Varghese BT, Prakash O, Pillai MR. NF-κB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol 2006;81:123-30.
32. Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F. NF-κB expression in oral and cutaneous lichen planus. J Pathol 2003;201:466-72.
33. Atula T, Hedstrom J, Ristimaki A, Finne P, Leivo I, Markkanen-Leppanen M, Haglund C. Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome. Oncol Rep 2006;16:485-90.
34. Shishodia S, Koul D, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-κB activation through inhibition of activation of IκBα kinase and Akt in human nonsmall cell lung carcinoma: correlation with suppression of COX-2 synthesis. J Immunol 2004;173;2011-22.
35. Shishodia S, Aggarwal BB. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-κB by suppressing activation of IκBα kinase in human nonsmall cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Res 2004;64:5004-12.
36. Anto RJ, Mukhopadhyay A, Shishodia S, Gairola CG, Aggarwal BB. Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκB(α): correlation with induction of cyclooxygenase-2. Carcinogenesis 2002;23:1511-18.
37. Stepanov I, Hecht SS, Ramakrishnan S, Gupta PC. Tobacco specific nitrosamines in smokeless tobacco products marketed in India. Int J Cancer 2005;116:16-19.
38. Ho YS, Chen CH, Wang YJ, Pestell RG, Albanese C, Chen RJ, Chang MC, Jeng JH, Lin SY, Liang YC, Tseng H, Lee WS et al. Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NF κB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 2005;205:133-48.
39. Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, Sayyah J, Dennis PA. Tobacco components stimulate Akt-dependent proliferation and NF κB-dependent survival in lung cancer cells. Carcinogenesis 2005;26:1182-95.
40. Ye YN, Liu ES, Shin VY, Wu WK, Cho CH. The modulating role of nuclear factor-κB in the action of α7-nicotinic acetylcholine receptor and cross-talk between 5-lipoxygenase and cyclooxygenase-2 in colon cancer growth induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther 2004;311:123-30.
41. Stich HF, Parida BB, Brunnemann KD. Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of reverse smokers, Khaini-tobacco chewers and gudakhu users. Int J Cancer 1992;50:172-6.
42. Stich HF, Anders F. The involvement of reactive oxygen species in oral cancers of betel quid/tobacco chewers. Mutat Res 1989;214:47-61.
43. Bagchi M, Bagchi D, Hassoun EA, Stohs SJ. Subchronic effects of smokeless tobacco extract (STE) on hepatic lipid peroxidation, DNA damage and excretion of urinary metabolites in rats. Toxicology 1998;127:29-38.
44. Bagchi M, Balmoori J, Bagchi D, Ray SD, Kuszynski C, Stohs SJ. Smokeless tobacco, oxidative stress, apoptosis, and antioxidants in human oral keratinocytes. Free Radic Biol Med 1999;26:992-1000.